Close
HomeOther Non-Program Research & Development

Other Non-Program Research & Development

Registry Data

Training requirements to master inhaler devices available in real-life clinical practice

Characteristics of asthma patients at risk of failed Diskus use in primary care

Databases

Evaluation of current implementation of BTS/NICE clinical quality standards in community acquired pneumonia (CAP)

Characterising patient pathways to the diagnosis of idiopathic pulmonary fibrosis

Inhaled Corticosteroid And Real life Unlicensed Spacer use (ICARUS)

Identifying opportunities for earlier diagnosis of idiopathic pulmonary fibrosis in routine care in the UK

Extrafine versus fine inhaled corticosteroids in relation to asthma control

Real-life effectiveness evaluation of asthma treatment in Korea

Real-life effectiveness evaluation of budesonide/formoterol (BF) Spiromax for the management of asthma and COPD

The burden of rhinitis in Australia

Real-world effectiveness of extra-fine Ciclesonide (Alvesco®) versus standard particle inhaled corticosteroid (ICS)

An observational evaluation of prescribing of fixed-dose combination inhaled corticosteroid / long-acting beta2-agonist (ICS/LABA): fluticasone propionate / formoterol (FP/FOR) and adverse events in routine primary care at 18-months and 36-months post launch

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma

Management of Asthma in School age Children On Therapy (MASCOT)

The use of a spacer in the delivery of large (Fluticasone Propionate) and small particle (Qvar®) inhaled corticosteroid (ICS) in asthma

Comparative effectiveness and safety of Ipramol (ipratropium/albuterol) SteriNebs® vs. DuoNeb®

Comparative effectiveness and safety of Salbutamol Sterinebs® vs Ventolin Nebules® in COPD patients

Comparative effectiveness and safety of Budesonide Sterinebs ® vs. Pulmicort Respules ® in a US population of asthma patients

Characterising patients and examining real-life outcomes for UK patients with COPD initiating on or changing to Fostair

Excess costs associated with possible misdiagnosis of Alzheimer’s disease among patients with vascular dementia in a UK CPRD population

Comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease

Benefits of pMDI versus Diskus for delivering fluticasone/salmeterol combination therapy in patients with chronic obstructive pulmonary

Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems

Increased dose of inhaled corticosteroid versus add-on long-acting β-agonist for step-up therapy in asthma

Exacerbation rates in adolescent and adult patients initiating inhaled corticosteroids for asthma: different dose-response profile by particle size

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide

UK prescribing practices as proxy markers of unmet need in allergic rhinitis

Real life effectiveness and cost impact evaluation of fixed dose combination fluticasone propionate/formoterol (Flutiform®) compared to fluticasone propionate/salmeterol (Seretide®)

Validation of real-life asthma research endpoints

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD

Real-world effectiveness of extra-fine formulations in Denmark

Switching patients from other inhaled corticosteroid devices to the Easyhaler® in real-life asthma patients

Cardiovascular disease risk associated with exposure to pharmacological smoking cessation interventions in a representative UK primary care patient population

Off-label prescribing and safety of glycopyrronium bromide for symptomatic treatment of severe sialorrhoea (drooling) and/or hyperhidrosis (excessive sweating)

Trends of testing for and diagnosis of alpha-1 antitrypsin deficiency in the UK

Use of degarelix among patients with prostate cancer in daily practice

The effect of DPP-4 inhibitors on asthma control: a potential pathophysiological relationship

Pragmatic Trials

Handling Inhalers – Technique Error Comparison (HI-TEC)

Easy Low Instruction Over Time (ELIOT)

Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease

Publications

News & Social Media

Social Feeds

OPRI © 2021 All Rights Reserved